Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02634463Phase 1Completed
Phase 1, open-label, single-arm trial, sponsored by Janssen Pharmaceutical. Primary endpoint: Immunoassay Antipsychotic In Blood up to 1 year. Started Nov 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02634463.